Sensitive Analysis of Blonanserin, a Novel Antipsychotic Agent, in Human Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
Authors:
Open Access
- 10 October 2010
- journal article
- Published by Springer Nature in Analytical Sciences
- Vol. 26 (10) , 1099-1102
Abstract
A rapid and sensitive method for analysis of blonanserin in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry is presented. After pretreatment of a plasma sample by solid-phase extraction, blonanserin was analyzed by the system with a C18 column. This method gave satisfactory recovery rates, reproducibility, and good linearity of calibration curve in the range of 0.01 – 10.0 ng/mL for quality control samples spiked with blonanserin. The detection limit was as low as 1 pg/mL. This method seems very useful in forensic and clinical toxicology and pharmacokinetic studies.Keywords
This publication has 19 references indexed in Scilit:
- Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five casesAnnals of General Psychiatry, 2010
- Simple analysis of blonanserin, a novel antipsychotic agent, in human plasma by GC-MSForensic Toxicology, 2010
- Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's diseaseAnnals of General Psychiatry, 2010
- BlonanserinCNS Drugs, 2010
- Identification of a cannabimimetic indole as a designer drug in a herbal productForensic Toxicology, 2009
- A fatal case of poisoning by lormetazepamForensic Toxicology, 2008
- Detection and identification of atypical quetiapine metabolite in urineOpen Medicine, 2008
- A case of abuse in which children were forced to take tablets containing scopolamine: segmental analysis of hair for scopolamine by ultra performance liquid chromatography-tandem mass spectrometryForensic Toxicology, 2007
- Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agentBioorganic & Medicinal Chemistry Letters, 2005
- Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in miceNeuroReport, 2003